BACKGROUND/OBJECTIVES: Often recommended, calcium supplements have been incriminated as increasing the risk of cardiovascular events, whereas dietary calcium has generally been exonerated. As a first step to address the vascular safety of such dietary measures at the clinical nutritionist toolbox, we sought to determine and compare the acute effects of a typical oral calcium load, provided either as a supplement or as food, on vascular parameters assessed noninvasively in healthy subjects. SUBJECTS/METHODS: In this acute, cross-over, random-order intervention, 11 young and healthy vitamin D-sufficient volunteers (8 women/3 men, 33 ± 6.1 years, body mass index 22.6 ± 2.3 kg/m 2 ), ingested 600 mg of calcium twice, once as calcium citrate and the other time from dairy products. Biochemical, vascular and hemodynamic parameters, before and 2 h after each challenge, were compared. Arterial stiffness was studied by measuring pulse wave velocity, augmentation index and large (C1) and small (C2) arterial compliance. Endothelial function was assessed by flow-mediated dilation (FMD). RESULTS: Despite effective calcium loading accompanied by a significant 60% parathyroid hormone level reduction on both occasions, there were no clinically significant changes in the vascular parameters neither in comparison with baseline, nor between the studies. A decrease in heart rate with no change in cardiac output was noticed after the supplement. CONCLUSIONS: An effective calcium load has no clinically significant untoward effect on the vascular properties of young healthy subjects, regardless of its source. Additional studies should determine whether this holds true for chronic calcium supplementation, particularly in subjects with a priori vascular impairment.
INTRODUCTION
As calcium consumption from food often fails to provide the required daily allowance, calcium supplementation has become a mainstay of osteoporosis prevention and treatment. 1, 2 Epidemiologic data and a few interventional studies suggested that calcium supplementation could have some cardiovascular (CV) health benefits by reducing blood pressure 3 and by increasing the ratio of high-density lipoprotein cholesterol to low-density lipoprotein cholesterol in postmenopausal women. 4 However, recent studies have casted some insecurity concerning these common recommendations, and suggested that calcium supplementation may be associated with an increased incidence of CV events among older women [5] [6] [7] and men. 8 To this date, no randomized controlled trials of calcium supplementation have set CV events as their primary end point. Several studies have been published in recent years presenting secondary analyses of such trials yielding inconsistent results. [5] [6] [7] 9, 10 Deriving their conclusions from the Auckland calcium study, Bolland et al. 5 promoted the notion for a potential adverse effect of calcium supplementation on CV events in postmenopausal women followed for 5 years. In contrast, studying a very similar population, under a comparable study design, Lewis et al. 9 found no untoward CV effect of calcium supplements. Atop this controversy, the recent EPIC-Heidelberg prospective observational study rekindled the debate by showing an increased risk for myocardial infarction among calcium supplement users versus non-users. This study also suggested a protective effect of dietary calcium on myocardial infarction and stroke. 10 Although the mechanisms by which calcium supplements increase CV morbidity are still speculative, it has been suggested that the risk might be lower or even nil when calcium is provided from food sources, as serum calcium transients are not as steep as those seen following the ingestion of a supplement.
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Under this tenet, we tested the hypothesis that a typical acute oral calcium load, such as induced by either a commonly used calcium supplement or from a dairy product-rich meal would have divergent effects on vascular parameters such as arterial stiffness and endothelial reactivity in young healthy subjects.
MATERIALS AND METHODS

Study design and subjects
In this cross-over study, each subject underwent, in random order, at least a week apart, an acute oral calcium challenge either in the form of calcium citrate or provided as a low-fat dairy product (detailed below). A battery of noninvasive tests to assess vascular compliance and endothelial function was administered before the beginning, and 2 h after each of the challenges. The protocol was approved by the institutional ethics committee at Tel Aviv Sourasky Medical Center, and all subjects gave written informed consent.
Eleven healthy volunteers comprised the study group, which included eight women and three men. The mean age was 33 ± 6.1 years (range 21-41 years). All were lean, nonsmoking, moderately physically active, and with no history of chronic medication use with the exception of oral contraceptives. All were vitamin D-sufficient (25-OH-vitamin D3 ⩾ 25 ng/ml (65 nmol/l)), and were not taking any dietary supplements. Demographic information, including medical history and other lifestyle factors were obtained using standard questionnaires and structured interviews. Weight and height were measured, and body mass index was calculated as weight (kilograms) divided by height (meters) squared. Dietary calcium intake was estimated from food diaries in which the subjects were required to record in a detailed fashion any food intake and portion size during the 3 days preceding each calcium-loading challenge. Subsequently, dietary nutrient intakes were calculated using a culturally-specific, and validated, food composition software-Tzameret v.2.0 (2007) (developed by the Department of Clinical Nutrition, Israel Ministry of Health). In addition, participants were asked to report the frequency of usual daily physical activity during the past 3 months.
Study protocol
Each participant reported after an overnight fast to the clinical research unit of the endocrinology institute at Tel Aviv Sourasky Medical Center. Upon arrival, subjects were requested to void. Following 1 h rest, urine and blood were sampled, and baseline noninvasive vascular studies were performed as detailed below. Each participant then ingested either 600 mg of calcium citrate with 500 ml of mineral water, or one cup of 0% fat yogurt with two slices of low-fat (9%) Swiss cheese and a glass of mineral water over the course of 10 min. One hour later, subjects were requested to void. Two hours after the calcium load, urine and blood samples were obtained again and the vascular studies were repeated. This timing was chosen on the basis of the kinetics for peak serum calcium and PTH nadir following an acute oral calcium supplement challenge. 
Vascular studies
Measurements were made between 0800 and 1000 hours and between 1000 and 1200 hours in the supine position in a quiet, temperaturecontrolled room (22 ± 1°C). Noninvasive assessment of arterial properties was initiated following the measurement of blood pressure, measuring several vascular functions with the following devices in this order.
Arterial rigidity/elasticity 1. The SphygmoCor system (AtCor Medical, Sydney, NSW, Australia):
peripheral pressure waveforms were recorded from the radial artery at the wrist using applanation tonometry as described. 13, 14 The augmentation index (AIx) was defined as the augmentation pressure divided by pulse pressure (expressed in percentage) and was normalized for a heart rate of 75 b.p.m. according to the method of Wilkinson et al. 15 2. Pulse wave velocity (PWV) was with the aid of the Complior device (Alam Medical, Vincennes, France), and calculated from the pulse transit time between the right common carotid and the right femoral arteries. [15] [16] [17] The more rigid the arteries, the greater the speed of spread of the pressure wave across the arterial compartment. 3. Systemic arterial stiffness was derived from analysis of the diastolic blood pressure decay using a Windkessel model with the aid of the CR-2000 instrument (Hypertension Diagnostics, Eagan, MN, USA). Through computerized analysis, the model defines two arterial compliance indices, the total systemic large artery compliance C1 and C2, an index of small artery elasticity. In addition, this system also provides noninvasive determination of stroke volume, cardiac output and cardiac index. 18 Pulse wave analysis was performed in duplicates and average values were reported. All results were adjusted for age, gender, and mean arterial pressure.
Endothelial function
Endothelial function was inferred from flow-mediated dilation (FMD) following transient forearm occlusion, using a high-frequency (7.5 MHz) linear-array transducer (ProSound 4000, Hitachi Aloka, Tokyo, Japan) according to the guidelines of the International Brachial Artery Reactivity Task Force. 19 FMD was determined as the average change from baseline diameter of quadruplicate measurements. Subsequently, the artery diameter was measured 5 min after sublingual application of nitroglycerin (0.3 mg) to assess endothelium-independent vasodilation.
Intima-media thickness (IMT) measurement
IMT is probably the most accepted marker of early atherosclerosis. IMT is an independent predictor of future vascular events and regresses impressively with therapeutic measures such as statins and Mediterranean diet. 20 IMT was measured at the left and right common carotid arteries with a high-resolution B mode ultrasound system (ProSound 4000), and analyzed offline by automated wall tracking software (MedicaSoft IMT.lab, Creteil, France), as previously described. 13, 14 The American Society for Echocardiography recommendations were followed to define the presence of plaque. 21 All measurements were performed by a single investigator (MY). Intraobserver reliability was measured by the Pearson's correlation coefficient and high reliability was found for each of the four parameters (C1, C2, PWV and AIx), respectively, with a correlation coefficient r = 0.92. Intraobserver reliability coefficients for IMT and FMD were 0.90 and 0.88, respectively.
Statistical methods
Results are presented as mean ± s.d. Paired t-test or repeated measures analysis of variance were used to compare the parameters at baseline and following the calcium loads, and to compare the two interventions. Correlations were established using Pearson's or Spearman's correlations. All statistical analyses were performed using GraphPad InStat version 3.00 (GraphPad Software, San Diego, CA, USA). Statistical significance was assumed as Po0.05.
RESULTS
The features of the participants are shown in Table 1 . All subjects were lean, normotensive, they had adequate vitamin D levels and a moderate to good daily calcium intake. All female subjects had regular menses, three of them were using combined oral contraceptives.
Biochemistry
As evidenced by PTH suppression, effective calcium loading was clearly achieved on both occasions. Total serum calcium rose significantly over the baseline value only after the calcium citrate supplement, whereas the rise after the meal was not significant (P = 0.2) (Figure 1a) . However, when serum calcium concentrations were corrected for albumin, the food challenge resulted in a significant increase over baseline, from 2.21 ± 0.11 to 2.28 ± 0.07, P = 0.045. The corresponding values for the supplement were 2.21 ± 0.07 at baseline and 2.31 ± 0.08 after the challenge, P = 0.0025. This was mirrored by the increase in urinary calcium to creatinine ratio after the challenge. Under both interventions this almost doubled, but only in the case of the calcium Abbreviations: BMI, body mass index; BP, blood pressure.
Vascular effects of an acute oral calcium challenge M Yaron et al supplement did the ratio increase significantly over baseline (Figure 1b) , supporting the notion that the absorption of any given amount of calcium occurs more rapidly when it originates from a supplement than when it is provided from dairy products. Nonetheless, both challenges were equally efficient at suppressing PTH by~60% (Figure 1c) . Finally, serum phosphorus was not significantly altered by either challenge within the time frame of the observation (Figure 1d ).
Vascular function
In this group of young, healthy individuals with no vascular risk factors, an acute calcium load had no compelling impact on the noninvasive vascular functions we assessed (Table 2) . PWV, AIx, FMD and large arterial compliance C1 were not affected by either challenge, neither in comparison with baseline values nor between the studies. Not given in the table, IMT was determined once and was normal in all subjects 609 ± 76 μm. The interventions appeared to have divergent effects on C2, the index of small artery compliance. Indeed, the post-challenge C2 value increased after food, whereas it decreased after the supplement, creating a significant post-challenge difference. However, as all the baseline and post-challenges C2 values were well in the normal range, the significance of this finding is unclear.
The only significant hemodynamic effect we observed was a reduction in heart rate following the oral calcium supplement intervention. This effect appeared to be positively correlated with the serum calcium excursion following the challenge, r = 0.49, P = 0.03. As there was no change in cardiac output, this is consistent with the increase in stroke volume that compensated for this reduction.
All other attempts at detecting correlations between any of the vascular functions assessed and biochemical parameters in this homogeneous group of healthy subjects were unsuccessful.
DISCUSSION
Considered a safe and efficient practice to prevent and manage osteoporosis, calcium supplementation has recently come under fire for increasing the risk of myocardial infarction both in older women [5] [6] [7] and in men. 8 Although none of the prospective calcium supplement studies had CV primary end points, together with widely published post hoc evaluations of large-scale prospective studies and meta-analyses, [6] [7] [8] 10 a notion has emerged that calcium supplementation may do more harm than good. Far from being universally endorsed, 9, 22, 23 this notion has certainly made its way into the general public's awareness. Divergent conclusions stemming from the very same Women's Health Initiative database 6, 7, 22 added further confusion. Evidence linking higher serum calcium to increased CV events has been first presented in hyperparathyroidism and has been later extended to subjects with high normal serum calcium concentrations. 24 Increases in serum calcium have been implicated in promoting vascular calcification, arterial stiffening and acceleration of atherosclerosis. Calcium supplements are under particular scrutiny as potential instigators of vascular calcification in light of the acute and recurring excursion of serum-ionized calcium that rapidly follows the ingestion of a supplement and lasts for several hours. This contrasts with the much more gradual absorption of calcium coming from food. [25] [26] [27] This difference is thought to underlie the presumed opposing protective effect of dietary calcium 28 vs the alleged deleterious effect of calcium supplements on CV health.
Although this subject can be resolved in prospective comparative interventional trials with CV end points, the need, ethics and practicality of such studies are all under debate. 11, 23 Until such studies are undertaken, better insight into the effects of dietary vs supplementary calcium in humans can be only gained through small studies with well-defined surrogate interim goals.
In the current study we recorded 'head-to-head', under controlled conditions, the immediate CV response to two of the most common nutritional means to increase calcium intake orally, that is, consuming either a calcium-rich meal or a calcium supplement. The selection of young and healthy subjects allowed us to define the basic vascular response patterns, uncomplicated by potential confounders such as age, disease or concomitant medications.
Our study group enjoyed excellent vascular health by all parameters: excellent vascular elasticity (low PWV and AIx), good arterial compliance (C1, C2) and a normal IMT essentially ruled out unsuspected atherosclerosis. In addition, FMD was well in the normal healthy range for our laboratory, attesting to good endothelial function in all subjects. As expected, the calcium citrate supplement resulted in a significant increase in serum and in urinary calcium compared with baseline, whereas the effect appeared less pronounced with the food challenge. Nonetheless, both challenges were equally effective in suppressing PTH by 60% compared with baseline, highlighting the reported exquisite sensitivity of PTH regulation to minor alterations of serum calcium in healthy subjects.
In spite of this clear evidence for effective calcium loading, none of the interventions had any clinically significant impact on the parameters studied.
The only notable hemodynamic effect was a decrease in heart rate seen with the supplement, which correlated with the rise in serum calcium, and was not associated with a decrease in cardiac output or a change in blood pressure. In addition, the two interventions appeared to have divergent effects on C2. This small artery elasticity index C2, assessed through analysis of the diastolic blood pressure decay, provides a noninvasive technique to assess small microcirculatory artery functional behavior that may be influenced by structural changes and by the local concentration of vasoactive substances. 17 In this acute study, it appeared that a calcium load coming from food had a favorable impact by increasing C2, whereas this was not the case when the same amount originated from the supplement. Intriguing as such possible beneficial vascular effect for calcium coming from dairy products might be, this finding has to be interpreted with much caution as all baseline and post-challenge C2 values were in the very healthy range. Hence, it could simply represent a chance finding. Nonetheless, given the opposed directions of the changes of C2 under the two challenges, and their potential significance, it will be of interest to prospectively assess this after chronic calcium supplementation.
Burt et al. 29 have recently examined CV function following an acute challenge of 1000 mg calcium citrate in 25 older subjects. Having used a clearly higher dose than the one we administered, in agreement with our findings, these investigators still observed no change in endothelial function. Their assessment of the effect of calcium supplements on arterial stiffness yielded a mixed outcome. Much like in our study, the oral calcium supplement did not affect PWV in their hands. However, in contrast to our findings, oral calcium citrate did improve another measure of large artery stiffness, by inducing a significant~10% decrease in AIx. An inherent limitation to the comparison between Burt's study and our results resides in the study populations: their subjects were much older, some had hypertension and hypercholesterolemia, factors known to elevate the AIx, which was in the order of 30% as opposed to 10-13% in our subjects. Another similar effect in Burt's study and our own trial was a significant decrease in heart rate following the calcium supplement.
The technology for advanced noninvasive vascular function assessment has been available for over a decade and its ability to forecast clinical outcomes in populations has been repeatedly shown. 30, 31 The European Society of Hypertension recently embraced such measures as markers of end-organ damage to initiate treatment. 32 In this context it is noteworthy that PWV was inversely associated with dietary calcium intake in two recent studies. 33, 34 In addition, there was no association between coronary artery calcification and oral calcium supplements in two independent studies 35, 36 The observations in the present report cannot be extended to indicate potential long-term differences between the source of oral calcium intake and its putative CV outcome. From a practical point of view, however, and given the public scare that calcium can be harmful, the immediate implications of this study are not trivial. Despite the induction of the expected rise in serum and urinary calcium with a concordant diminution in circulating PTH, food-derived calcium and calcium supplement appear to be free of negative effects on vascular homeostasis in the acute setting in young and healthy subjects. This basic pattern can now be retested in less-fortunate patient populations often offered calcium enrichment through one mode or another, such as the elderly, osteoporotic, hypertensive, atherosclerotic and those with renal disease.
Taken together with the data from the study by Burt et al. 29 and the cross-sectional and prospective population data, our results suggest that increased calcium intake, in a dose commonly given to meet recommended daily allowances, has no apparent untoward effect on arterial stiffness or endothelial function. Until the results of long-term interventional studies are available, this information may help alleviate some of the fears recently associated with the use of calcium supplements.
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